Phoenix Financial Ltd.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1679543
Givatayim, L3
Position in TEVA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,288,455,709
+$6,126,351 QoQ
Shares Held
42,777,414
+4.1% QoQ
Ownership
3.67%
of shares outstanding
% of Portfolio
20.65%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Dec 31, 2024CallValue
$16,309,600
CallShares
740,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Phoenix Financial Ltd. holds $1,303,872,356 across 4 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (98.8% of the industry book) .
All Filings in TEVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,288,455,709 | 42,777,414 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,282,329,358 | 41,087,131 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $834,163,928 | 41,295,244 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $632,881,801 | 37,761,444 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $422,130,470 | 27,464,572 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $16,309,600 | 740,000 | Call | Sole | 2025-02-13 | |
| 2024-12-31 | $467,524,425 | 21,212,542 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $406,561,401 | 22,561,676 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $413,117,185 | 25,422,596 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $487,949,014 | 34,581,787 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $358,960,524 | 34,383,192 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $351,713,258 | 34,481,692 | Shares | Sole | 2023-12-04 | |
| 2023-06-30 | $253,786,677 | 33,703,410 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $195,884,147 | 22,133,802 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $202,085,985 | 22,158,551 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $168,106,815 | 20,831,080 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $139,344,012 | 18,529,789 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $156,807,374 | 16,699,401 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $121,642,270 | 15,186,301 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $138,023,601 | 14,170,801 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $114,345,009 | 11,550,001 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $133,588,574 | 11,576,133 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $83,222,438 | 8,624,087 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $100,476,600 | 11,151,676 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $144,070,981 | 11,684,589 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $101,737,733 | 11,329,369 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||